FRMD8P1

Model summary

A human cytoplasmic scaffold that uses a FERM-based architecture to assemble membrane-proximal signaling complexes. By anchoring and stabilizing protein assemblies at junctional and receptor interfaces, it enhances cytokine signaling pathways that drive tumor necrosis factor production. The scaffold likely cycles between cytoplasmic pools and membrane-adjacent sites and can be packaged into extracellular vesicles, consistent with its detection in exosomes. Its mechanism centers on multivalent protein binding that organizes and prolongs the residence of signaling modules controlling inflammatory outputs.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   A single, continuous FERM scaffold dominates the sequence: IPR000299 (FERM domain, residues 30–369) spans nearly the entire protein and is refined by multiple overlapping signatures that map its internal lobes. The N-to-C layout is characteristic of FERM tripartite folds. The central lobe is reinforced by IPR035963 (FERM superfamily, second domain, residues 127–267) and IPR019748 (FERM central domain, residues 136–272), while the C-terminal lobe is specified by IPR057096 (KRIT1/FRMD8, FERM domain C-lobe, residues 291–364). The FERM fold is further supported by IPR014352 (FERM/acyl-CoA-binding protein superfamily, residues 134–266), indicating a conserved β-sandwich architecture that mediates membrane-proximal protein interactions. Immediately following, IPR011993 (PH-like domain superfamily, residues 267–368) and IPR051594 (KRIT1/FRMD8 family, residues 27–369) consolidate the identity of a KRIT1/FRMD8-like FERM module. This ordered architecture causes high-avidity binding to membrane-proximal partners and cytoskeletal adaptors rather than catalysis, predicting a primary molecular function of multivalent protein binding (GO:0005515).

2. 02

   A FERM core typically anchors signaling assemblies at the cytoplasmic face of membranes and at junctional complexes.

   The KRIT1/FRMD8 family signature (IPR051594) narrows the functional niche to membrane-associated scaffolding that tunes receptor-proximal pathways. Such scaffolds often modulate inflammatory signaling by organizing adaptors and effectors that control cytokine production. This mechanistic role aligns with positive regulation of tumor necrosis factor production (GO:0032760): by stabilizing membrane-tethered signaling hubs, the FERM module can enhance assembly and persistence of TNF-producing pathways.

3. 03

   Cellular placement follows from the same architecture.

   FERM domains concentrate at membrane-proximal cytoplasmic regions and junctional interfaces, consistent with a soluble cytoplasmic pool and membrane-adjacent assemblies. The presence of a PH-like C-lobe and KRIT1/FRMD8 family features supports packaging into extracellular vesicles; this explains detection in extracellular exosomes (GO:0070062). Thus, the protein resides in the cytoplasm and is exported via exosomal pathways.

4. 04

   Mechanistically, the FERM tri-lobe scaffold recruits membrane receptors and cytoskeletal adaptors to nucleate signaling complexes that potentiate TNF production.

   I hypothesize that it binds and stabilizes junctional and receptor-proximal assemblies—potentially coupling to tight-junction or integrin-associated modules—thereby prolonging signalosome residency and amplifying downstream cytokine output. Likely interaction partners include membrane receptor tails and adaptor proteins that recognize FERM folds, with exosome biogenesis factors mediating vesicular export.